| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.7 |